{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:54:51Z","timestamp":1778162091885,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.medcli.2024.09.032","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T12:26:10Z","timestamp":1732796770000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of pentoxifylline on hepcidin and iron profile in hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.1016","volume":"164","author":[{"given":"Hadeer","family":"Zakaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha Alaa","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagy A.H.","family":"Sayed-Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"El-Mallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.09.032_bib0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12882-019-1492-x","article-title":"Usefulness of mid-week hemoglobin measurement for anemia management in patients undergoing hemodialysis: a retrospective cohort study","volume":"20","author":"Bae","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.medcli.2024.09.032_bib0145","first-page":"55","article-title":"Anemia in chronic kidney disease","volume":"66","author":"Hazin","year":"2020","journal-title":"Rev Bras Educ Med"},{"key":"10.1016\/j.medcli.2024.09.032_bib0150","doi-asserted-by":"crossref","first-page":"7692376","DOI":"10.1155\/2020\/7692376","article-title":"The impact of CKD anaemia on patients: incidence, risk factors, and clinical outcomes\u2014a systematic literature review","volume":"2020","author":"Palaka","year":"2020","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.medcli.2024.09.032_bib0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3945\/an.116.013961","article-title":"Regulation of the iron homeostatic hormone hepcidin","volume":"8","author":"Sangkhae","year":"2017","journal-title":"Adv Nutr"},{"key":"10.1016\/j.medcli.2024.09.032_bib0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semnephrol.2016.02.001","article-title":"Iron balance and the role of hepcidin in chronic kidney disease","volume":"36","author":"Ganz","year":"2016","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.medcli.2024.09.032_bib0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/14728222.2019.1599358","article-title":"Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease","volume":"23","author":"Malyszko","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.medcli.2024.09.032_bib0170","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/ckj\/sfac143","article-title":"Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease","volume":"15","author":"Donate-Correa","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.medcli.2024.09.032_bib0175","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/ndt\/gfr579","article-title":"Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial","volume":"27","author":"Gonz\u00e1lez-Espinoza","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.medcli.2024.09.032_bib0180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.5301\/ijao.5000340","article-title":"Pentoxifylline does not alter the concentration of hepcidin in chronic kidney disease patients undergoing hemodialysis","volume":"37","author":"Antunes","year":"2014","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.medcli.2024.09.032_bib0185","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/nep.12815","article-title":"Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial","volume":"22","author":"Gummer","year":"2017","journal-title":"Nephrology"},{"key":"10.1016\/j.medcli.2024.09.032_bib0190","first-page":"14","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. Practice guideline","volume":"81","year":"2014","journal-title":"J Am Coll Dent"},{"key":"10.1016\/j.medcli.2024.09.032_bib0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0976-500X.72352","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"1","author":"Schulz","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.medcli.2024.09.032_bib0200","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jcp.31.6.507","article-title":"Enzyme immunoassays with special reference to ELISA techniques","volume":"31","author":"Voller","year":"1978","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.medcli.2024.09.032_bib0205","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/jcp.43.7.610-b","article-title":"Colorimetric determination of human albumin. Letter","volume":"43","author":"Hinton","year":"1990","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.medcli.2024.09.032_bib0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0009-8981(79)90003-2","article-title":"A highly sensitive, simple determination of serum iron using chromazurol B","volume":"94","author":"Garcic","year":"1979","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.medcli.2024.09.032_bib0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0009-8981(88)90169-6","article-title":"Modification in Ramsay's method for correct measurement of total iron-binding capacity","volume":"176","author":"Baadenhuijsen","year":"1988","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.medcli.2024.09.032_bib0220","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.3390\/ijms22126493","article-title":"Hepcidin-ferroportin interaction controls systemic iron homeostasis","volume":"22","author":"Nemeth","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.medcli.2024.09.032_bib0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5455\/medarh.2012.66.84-86","article-title":"Role of pentoxifylline in treatment of anemic patients suffering chronic hemodialysis: a randomized clinical trial, randomized controlled trial","volume":"66","author":"Mortazavi","year":"2012","journal-title":"Med Arh"},{"key":"10.1016\/j.medcli.2024.09.032_bib0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13539-013-0115-9","article-title":"Anti-inflammatory and anti-oxidative nutrition in hypoalbuminemic dialysis patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial","volume":"4","author":"Rattanasompattikul","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.medcli.2024.09.032_bib0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.ajkd.2014.06.020","article-title":"A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial","volume":"65","author":"Johnson","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.medcli.2024.09.032_bib0240","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1440-1797.2009.01203.x","article-title":"Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease","volume":"15","author":"Ferrari","year":"2010","journal-title":"Nephrology"},{"key":"10.1016\/j.medcli.2024.09.032_bib0245","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI38499","article-title":"HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice","volume":"119","author":"Mastrogiannaki","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.medcli.2024.09.032_bib0250","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/ph12040170","article-title":"Therapeutic advances in regulating the hepcidin\/ferroportin axis","volume":"12","author":"Hawula","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.medcli.2024.09.032_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46439\/nephrology.4.013","article-title":"Effect of pentoxifylline on the dose of erythropoietin among hemodialysis patients: a double-blind randomized clinical trial","volume":"4","author":"Pakfetrat","year":"2023","journal-title":"J Exp Nephrol"},{"key":"10.1016\/j.medcli.2024.09.032_bib0260","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.21608\/mjcu.2019.59202","article-title":"Effect of pentoxifylline administration on hemoglobin level of hemodialysis patients","volume":"87","author":"Sarah","year":"2019","journal-title":"Med J Cairo Univ"},{"key":"10.1016\/j.medcli.2024.09.032_bib0265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.15171\/jrip.2017.11","article-title":"Administration of pentoxifylline to improve anemia of hemodialysis patients","volume":"6","author":"Shahbazian","year":"2017","journal-title":"J Renal Inj Prev"},{"key":"10.1016\/j.medcli.2024.09.032_bib0270","first-page":"524","article-title":"Effect of pentoxifylline on anaemia control in haemodialysis patients: retrospective observational case-control study","volume":"33","author":"Mora-Gutierrez","year":"2013","journal-title":"Nefrologia"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324006547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324006547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T19:21:05Z","timestamp":1742671265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324006547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0025775324006547"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.09.032","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of pentoxifylline on hepcidin and iron profile in hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}